India Russia covid-19 vaccine India Russia

Drug regulator seeks more data from Dr.Reddy's on Sputnik V Covid-19 vaccine

Reading now: 777
www.livemint.com

Dr.Reddy's Laboratories on its Sputnik V COVID-19 vaccine trial, in its second such request after an initial evaluation in February.The committee asked the company to submit a comparative analysis of late-stage immunogenicity data from both its Indian studies and an ongoing Russian study, as well as data on serious adverse events and positive cases reported till date.Dr.Reddy's has been conducting small clinical trials with Sputnik V in India under a deal with Russia's wealth fund.

Several Indian companies have signed deals to produce and supply over half a billion doses of the vaccine.Click here to read the Mint ePaperMint is now on Telegram.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA